2012•China Practical MedicineRequires access

Edaravone joint ozagrel simvastatin treatment of acute cerebral infarction

Xiaoning Xu

Open publisher page 0 citations

Abstract

Objective To observe the edaravone and ozagrel sodium,simvastatin treatment of acute ischemic stroke clinical efficacy.Methods The incidence of ACI in the 48 h in 72 cases patients were randomly divided into treatment group(36 cases) and control group(36 cases),clinical neurological impairment score and the clinical efficacy of contrast.Results The total effective rate(83.33%) was significantly higher than that(66.67%),two groups were no obvious adverse reactions.Conclusion Edaravone with ozagrel sodium,simvastatin treatment of acute cerebral infarction precise and safe,is worth the clinical promoted use.

About this research paper

What this paper is about

Objective To observe the edaravone and ozagrel sodium,simvastatin treatment of acute ischemic stroke clinical efficacy.Methods The incidence of ACI in the 48 h in 72 cases patients were randomly divided into treatment group(36 cases) and control group(36 cases),clinical neurological impairment score and the clinical efficacy of contrast.Results The total effective rate(83.33%) was significantly higher than that(66.67%),two groups were no obvious adverse reactions.Conclusion Edaravone with ozagrel sodium,simvastatin treatment of acute cerebral infarction precise and safe,is worth the clinical promoted use.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the edaravone and ozagrel sodium,simvastatin treatment of acute ischemic stroke clinical efficacy.Methods The incidence of ACI in the 48 h in 72 cases patients were randomly divided into treatment group(36 cases) and control group(36 cases),clinical neurological impairment score and the clinical efficacy of contrast.Results The total effective rate(83.33%) was significantly higher than that(66.67%),two groups were no obvious adverse reactions.Conclusion Edaravone with ozagrel sodium,simvastatin treatment of acute cerebral infarction precise and safe,is worth the clinical promoted use.

Key concepts: Edaravone, Medicine, Simvastatin, Clinical efficacy, Anesthesia, Incidence (geometry), Adverse effect, Cerebral infarction

Related papers

Back to paper searchBrowse research topicsOriginal source
Edaravone joint ozagrel simvastatin treatment of acute cerebral infarction — Research Paper | ScholarLens